Zelira Therapeutics Ltd (ZLDAF) Stock Price & News

All values in AUD	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Revenue	328.00	328.00	-	-
Cost of goods sold	1.38K	1.38K	400.42K	400.42K
Cost of revenue	1.38K	1.38K	400.42K	400.42K
Research and development expenses	705.93K	705.93K	626.38K	626.38K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	521.79K	521.79K	314.23K	314.23K
Operating expense	729.85K	729.85K	1.03M	1.03M
Total operating expenses	731.23K	731.23K	1.43M	1.43M
Operating income	-730.90K	-730.90K	-1.43M	-1.43M
Other non operating income	-85.97K	-85.97K	525.32K	525.32K
EBT including unusual items	-1.24M	-1.24M	-682.66K	-682.66K
EBT excluding unusual items	-1.24M	-1.24M	-682.66K	-682.66K
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	47.85K	47.85K	1.39K	1.39K
Net income	-1.21M	-1.21M	-608.62K	-608.62K
Net profit margin	-367,475.61%	-367,475.61%	-	-
Earnings per share	-	-	-	-
Interest and investment income	-	-	221.69K	221.69K
Interest expense	-425.30K	-425.30K	-	-
Net interest expenses	-425.30K	-425.30K	221.69K	221.69K
Depreciation and amortization charges	75.05K	75.05K	60.19K	60.19K
EBITDA	-686.81K	-686.81K	-1.40M	-1.40M
Gain or loss from assets sale	-	-	-	-

Finance